Buy ENOVID Virx - SaNOtize Nitric Oxide Nasal Spray- Free DHL Shipping

Expiry Date March 2024

SaNOtize Nasal Spray

Sanotize Nitric Oxide Nasal Spray (NONS) - Your Daily Protection Against Viruses

Buy Now!
Customer Reviews

Why Sanotize?

Buy Enovid Online

Already tested positive?

99% Reduction in COVID-19 Viral Load

Glenmark Phase III clinical trial shows reduction in SARS-CoV-2 log viral load by 94% within 24 hours, and by more than 99% in 48 hours.

Buy Enovid Online

Stay Safe Everywhere

Protect yourself from viruses at work or school, during meetings or when using public transportation and flights.

Buy Enovid Online

Use SaNOtize NONS Daily

Enovid can be used as a proactive measure or to reduce the viral load. It kills viruses in the nasal cavity, the main "gateway" to viruses in the respiratory tract and significantly reduces the viral load in the body. Easy to use and made from natural ingredients only.

Videos About Enovid

Enovid News

Gilly Regev and Chris Miller write about The Power of Nitric Oxide on

"The Power of NO: How a Tiny Natural Molecule Can Help Shift How We Treat...
Read more

The Jerusalem Post: Can an anti-viral nasal spray stop Corona and other viruses?

"Enovid, an innovative anti-viral spray developed in Canada by an Israeli researcher and manufactured in...
Read more

SaNOtize moves to carve a new market demand: over-the-counter prevention

There are currently zero authorized or approved preventative COVID therapies in the U.S. but Canadian...
Read more

SaNOtize raised $24M to fund phase 3 trial of COVID-19 nasal spray

SaNOtize has raised a $24 million series B round, giving it the cash to fund its...
Read more

Clinical Study Suggests SaNOtize Nitric Oxide Nasal Spray Is Effective at Preventing COVID-19 after High-Risk Exposure

Published on May 11, 2022 on After confirmed exposure to COVID-19, infection rate in...
Read more

Phase 3 Clinical Trial Confirms SaNOtize’s Treatment is 99% Effective Against COVID-19

SaNOtize and Glenmark Pharmaceuticals Limited has announced on February 09, 2022: Phase 3 trial reached primary...
Read more

Outstanding Preliminary Results of A Clinical Trial Treating Moderate-To-Severe Covid-19 Patients, Conducted By Amorphical, An Israeli Biotechnology Company

Amorphical, an Israeli biotech company developing Amorphous Calcium Carbonate (ACC) has announced results of a...
Read more
You have successfully subscribed!
This email has been registered